Substance abuse treatment clinician opinions and infectious disease service delivery

Journal of Addictive Diseases

Volumn 28, Issue 1, 2009, Pages 8-12

  Tracy, Kathlene ^a,k   Brown, Lawrence S ^b,c   Kritz, Steven ^b   Alderson, Donald ^d   Robinson, Jim ^e   Bini, Edmund J ^a   Levy, Michael ^f   Calsyn, Donald ^g   Rieckmann, Traci ^h   Fuller, Bret ⁱ   McAuliffe, Pat ^j   Rotrosen, John ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Addiction Research and Treatment Corporation   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^f CAB Health and Recovery Services Inc   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^j Community Research and Prevention Program ^*  (United States)

^k NONE   (United States)

more..

Author keywords

Hepatitis C (HCV); Human immunodeficiency virus (HIV); Infectious disease treatment; Opinions; Sexually transmitted infections (STI)

Indexed keywords

ARTICLE; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SERVICE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL EDUCATION; MEDICAL INFORMATION; MEDICAL PRACTICE; PHYSICIAN; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SUBSTANCE ABUSE; VIRUS INFECTION;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; HEPATITIS C; HIV INFECTIONS; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; SEXUALLY TRANSMITTED DISEASES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 60749096833     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550880802544625     Document Type: Article

References (6)

1. Rothman J, Rudnick D, Slifer M, Agins B, Heiner K, Birkhead G. Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population. J Urban Health. 2007;84(2):226-242.
2. Edlin BR, Kresina TF, Raymond DB, Carden MR, Gourevitch MN, Rich JD, et al. Overcoming barriers to prevention, care, and treatment of Hepatitis C in illicit drug users. Clin Infect Dis. 2005;40(Suppl 5):S276-S285.
3. Vassilev ZP, Strauss SM, Astone J, Des Jarlais DC. Injection drug users and the provision of Hepatitis C-related services in a nationwide sample of drug treatment programs. J Behav Health Serv Res. 2004;31;2:208-16.
4. Strauss SM, Falkin GP, Vassilev Z, Des Jarlais DC, Astone J. A nationwide survey of Hepatitis C services provided by drug treatment programs. J Subst Abuse Treat. 2002;22;2:55-62.
5. Strauss SM, Astone J, Vassilev ZP, Des Jarlais DC, Hagan H. Gaps in the drug-free and methadone treatment program response to Hepatitis C. J Subst Abuse Treat. 2003;24;4:291-97.
6. Grossman H. Addressing the need for HIV specialists: The AAHIVM Perspective. CMP media inc. 2006.